About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Frontiers in Oncology
›
Top Articles
Frontiers in Oncology
Oncology
5.3
(top 2%)
Impact Factor
5.7
(top 2%)
extended IF
113
(top 3%)
H-Index
6.1K
authors
14.8K
papers
140.7K
citations
5.3K
citing journals
93.8K
citing authors
Most Cited Articles of Frontiers in Oncology
Title
Year
Citations
Targeting PI3K/Akt/mTOR Signaling in Cancer
2014
773
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
2018
529
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis
2015
414
Radiation-induced brain injury: A review
2012
371
Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
2018
356
Trastuzumab: updated mechanisms of action and resistance in breast cancer
2012
315
Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment
2014
294
DNA methyltransferases: a novel target for prevention and therapy
2014
293
Mitochondrial dysfunction in cancer
2013
293
PTEN: Multiple Functions in Human Malignant Tumors
2015
284
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
2013
258
Targeting Macrophages in Cancer: From Bench to Bedside
2018
254
Altered tumor-cell glycosylation promotes metastasis
2014
242
The Keap1-Nrf2 system in cancers: stress response and anabolic metabolism
2012
242
Role of Matrix Metalloproteinases in Angiogenesis and Cancer
2019
242
The KEAP1-NRF2 System in Cancer
2017
236
Radiomic Machine-Learning Classifiers for Prognostic Biomarkers of Head and Neck Cancer
2015
225
Clinical Overview of MDM2/X-Targeted Therapies
2016
215
Radiation as an immunological adjuvant: current evidence on dose and fractionation
2012
214
Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
2019
214
Microtubules and their role in cellular stress in cancer
2014
213
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology
2016
211
Lung Cancer: Understanding Its Molecular Pathology and the 2015 WHO Classification
2017
203
Targeting Oncogenic Mutant p53 for Cancer Therapy
2015
187
Control of the immune response by pro-angiogenic factors
2014
187
0
1
2
next
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.